2022 Biggest Medtech Losers Welcome a Fresh Year2022 Biggest Medtech Losers Welcome a Fresh Year

From major lawsuits and environmental controversy to recalls and botched M&A, these companies say good riddance to 2022.

Katie Hobbins, Managing Editor

January 9, 2023

7 Slides
thumbs down (Marina Demeshko) (1).jpg

Already have an account?

Image courtesy of Marina Demeshko / Getty Images

2022 is done. Finished. Kaput.

And these companies are saying good riddance.

However, before they get to start the year anew, lets take a look back at the biggest lawsuits, shortages, recalls, and other controversies that plagued 2022’s biggest losers.

About the Author

Katie Hobbins

Katie Hobbins

Managing Editor, MD+DI

Katie Hobbins is managing editor for MD+DI and joined the team in July 2022. She boasts multiple previous editorial roles in print and multimedia medical journalism, including dermatology, medical aesthetics, and pediatric medicine. She graduated from Cleveland State University in 2018 with a bachelor's degree in journalism and promotional communications. She enjoys yoga, hand embroidery, and anything DIY. You can reach her at [email protected].

See more from Katie Hobbins
Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like

Editors' Choice

Diabetes
Is Embecta Back on Track After a Tough Year?
Is Embecta Back on Track After a Tough Year?

Jan 16, 2025

Graphic featuring images and text of medtech topics in January, such as M&A, Industry 5.0, pulsed field ablation, supply chain management, CBD tampons
M&A
What Medtech Is Talking About in January
What Medtech Is Talking About in January

Jan 16, 2025

Automation
The Trends Shaping Medical Device Manufacturing in 2025
2025 Trends in Medical Device Manufacturing

Jan 16, 2025

Recent Headlines

Recommended